WHO vaccine-preventable diseases: monitoring system. 2014 global summary

Last updated 15-Jul-2014 (Data received as of 8-Jul-2014)
Next overall update Fall 2014
EPI mother and child logo         
Select a country

Development status: Economy in transition GNI / capita (US$): 3'5701 Infant (under 12 months) mortality rate: 182
GDP / capita (US$): 7'1651 Child (under 5 years) mortality rate: 202

Population data in thousands3

  2013  2012  2011  2010  2009  2000  1990  1980 
Total population 4'341  4'358  4'374  4'389  4'401  4'744  5'460  5'073 
Births 58  59  60  61  61  57  91  95 
Surviving infants 57  58  59  59  60  55  87  90 
Pop. less than 5 years 298  306  306  294  286  276  458  434 
Pop. less than 15 years 777  771  766  759  762  1'040  1'344  1'308 
Female 15-49 years 1'075  1'101  1'126  1'149  1'167  1'236  1'348  1'325 

Number of reported case

(Click for retrospective incidence data for Georgia)
Diphtheria 28 
Japanese encephalitis
Measles 7'872  31  64  22  23  50 
Mumps 52  50  44  101  42  2'646 
Pertussis 115  346  33  49  130  84 
Polio*
Rubella 224  75  64  59  67  428 
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total)
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Georgia)
Vaccine year result method % card seen                                                
BCG 1998  92  EPI   86  95  95  96  97  95  95 
DTP1 1998  87  EPI   86  100  94  95  100  99  99 
DTP3 1998  80  EPI   86  98  92  95  91  88  98 
HepB_BD          80  93  93  90  55 
HepB3          93  92  92  95  54  55 
Hib3          93  92  92  67 
JapEnc         
MCV 1998  73  EPI   86  97  93  94  94  83  97 
MCV2          89  84  77  84  71 
PCV1         
PCV3         
Pol3 1998  80  EPI   86  94  93  91  88  93  98 
Rota1          74 
Rota_last          56 
Rubella1          97  93  94  94  83 
TT2plus         
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Georgia)
BCG 95  95  96  96  95  95 
DTP1 99  94  95  99  99  89 
DTP3 98  92  94  91  88  80 
HepB3 93  92  92  95  54  55 
HepB_BD 93  93  93  90  55 
Hib3 93  92  92  67 
MCV 96  93  94  94  83  73 
MCV2 89  84  77  84  71 
PCV3
Pol3 94  93  90  88  93  81 
Rota_last 41 

Number of districts in the country 65  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 71
From 80 to 89% 23
From 50 to 79% 6
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2013 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG 0-5 days; Yes
DT 5 years; Yes
DTwP 18 months; Yes
DTwPHibHepB 2, 3, 4 months; Yes
HepB birth; Yes
MMR 12 months; 5 years; Yes
OPV 2, 3, 4, 18 months; 5 years; Yes
Pneumo_conj 2, 3, 4 months; Yes From June 2014
Rotavirus 2, 3 months; Yes
Td 14 years; Yes

Immunizaton indicators

Indicator Expected answer 2013  2012  2011  2010  2009  2008  2007 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2012-2016  2012-2016  2012-2016  2010/2015  2007-2010  2007-2010  2007-2010 
Nº of districts with microplans that include activities to raise immunization coverage number 65  65  65  63  65  66  66 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR No  No  No  No       

System performance

Total Nº districts in country number 65  65  65  65  65  66  66 
Nº districts with DTP3 coverage >=80% number 61  59  62  55  55  58 
% of districts with DTP3 coverage >=80% From 0 to 100% 94  91  95  85  85  88  12 
Nº districts with measles (MCV1) coverage >=95% number 41  31  35  43  45   
% of districts with MCV1 coverage >=95% From 0 to 100% 63  48  54  66  68   

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes       
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Estimated percentage of routine vaccines funded by Government From 0 to 100% 62  57  78  79  88  63  43 

Sources

 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.